Social Media Marketing for Private Clinics: A UK Guide to Strategy, Governance and Measurement

The first mistake in clinic social media is treating "patients" as a single audience. An insured patient arriving with a GP referral is making a different decision from a self-funding patient who found the clinic by searching at eleven at night, and both are different again from the corporate or sporting organisation buying a block of appointments. They compare different alternatives, they need different proof, and they arrive with different questions already answered.

The second mistake is ignoring the stage the reader is at. Most clinic content is written for the moment immediately before booking — availability, prices, how to contact — which is the shortest part of the journey and the part where the reader already knows what they want. The longer part is everything before that: someone who has a symptom, has not named it, and does not yet know whether their situation is a physiotherapy problem, a medical problem, or nothing at all. That is where a clinic is either known or not.

Mapping the journey is not a persona exercise. It is a list of the questions your front desk already answers every week, arranged in the order patients ask them — first without naming a clinic, then while comparing clinics, then after booking. The useful output is a one-page table: stage, what the patient is trying to work out, what would settle it, and which channel you would answer it on. Everything later in this guide hangs off that table, because channel choice, approval workflow, and measurement only make sense once you know which stage you are trying to reach.

An independent clinic has three real constraints: clinical time, a small number of people who can approve content, and a compliance surface that grows with every new format. A channel that cannot be staffed inside those constraints will be abandoned within a quarter, and an abandoned channel reads worse to a prospective patient than one that never existed.

It is more useful to think in terms of channel roles than channel popularity. Local discovery — how someone finds that a clinic exists near them at all — is what a well-maintained Google Business Profile does, including opening hours, services, and the way reviews are handled. Consideration is where the clinic's own site does the work, because that is where the reader checks qualifications, what a first appointment involves, and whether the clinic treats their specific problem. Familiarity and repeat contact is where a social profile earns its place: it keeps the clinic recognisable between the search and the decision, and it is the channel most clinic content is actually written for. A fourth role — supporting existing patients through recall, education, or aftercare — belongs to email and messaging, and carries its own consent requirements.

Short-form video deserves a specific warning rather than a recommendation. It performs well for reach, and it is the hardest format to keep inside a claims framework: it compresses the sentence that would have qualified the claim. If a clinic wants to use it, it needs a clinician willing to be on camera and an approval step that survives the edit — not a caption added afterwards.

The selection test is short. For each candidate channel, answer four questions: are my patients there at the stage I am trying to reach; can I publish on it steadily for a year; can I make the claims I want to make on it safely; and will I be able to see whether it did anything. A channel that fails any one of the four should be dropped rather than run badly.

Clinic content gets produced in one of three ways. Clinician-led: the clinical substance comes from interviews with a practitioner and everything else is production. Practice-manager-led: someone on the clinic side writes and publishes, with clinical sign-off where required. Agency-led: an outside team plans, produces, and publishes against an approval workflow. All three can work. What does not work is the undefined version, where everyone assumes someone else owns it — which is the state most clinics are actually in.

Ownership is three separate questions, not one. Who owns the accounts: the clinic, always — the profiles, the domain, the ad accounts, and the analytics. Who owns the content: the clinic should, including the raw interview recordings and the source files, because they are the clinic's clinical material in another form. Who owns the publishing decision: a named human at the clinic, with a deputy named alongside them, because an approval queue with one approver stops the moment that approver takes a holiday.

The failure mode that hurts most is continuity. When the person who has run the clinic's social media leaves — a practice manager, an associate, a family member — the clinic commonly discovers at that moment that the account logins went with them, the content calendar lived in a personal drive, and nobody knows which posts were ever signed off. Each of those is preventable at the setup stage by writing down access, ownership, and sign-off in one place, and re-checking it at the same time each year.

Whatever model you choose, put the operational detail in writing: who produces, who approves what category of claim, turnaround expectation, what happens during leave, and how the work ends. A written model also makes the compliance question answerable, because when the ASA or the ICO asks who decided that a claim could be published, there is an answer that does not depend on anyone's memory.

Clinical approval is where clinic marketing either becomes reliable or does not happen at all. The problem is rarely the approver's willingness; it is the shape of the request. Drafts that arrive one at a time, in a chat thread, with a question attached, are effectively unauthorised micro-meetings with someone who is also seeing patients. Batched, scheduled, and framed as a decision to be made, the same volume takes a fraction of the attention.

A workable workflow separates two kinds of sign-off. Clinical claims — anything a reader could take as a statement about a condition, a treatment, an outcome, or which patients a service suits — require a clinician's approval, and that clinician should be someone who can stand behind the claim professionally. Operational detail — hours, location, prices, booking routes, staff names, opening changes — is signed off by whoever owns that fact at the clinic. Separating the two means the busy clinical approver is not being asked to confirm a car-park postcode, and the practice manager is not silently approving a treatment claim by not objecting to it.

Consolidation is what makes the workflow survive a busy week. One review round per cycle, one consolidated comment pass, and a stated cut-off after which the content either publishes as approved or moves to the next cycle. Content that misses the cut-off should not be published on trust, and it should not be published late either — a post about a clinic's availability is only useful in the week it was written for.

Keep the record. For each published asset, hold the approved version, the date of approval, and the name of the person who gave it — separated into clinical and operational sign-off where both applied. That record is what lets a clinic answer a patient complaint, an internal query, or an advertising challenge with evidence rather than recollection. It is also what makes corrections auditable: a corrected post follows the same path as the original rather than being quietly edited.

An image of a patient in a clinic context is special category data under the UK GDPR, because it reveals health information — that this person attends this clinic, and often what for. Processing it needs a lawful basis under Article 6 and a condition under Article 9, and consent is the condition clinics will normally rely on. That consent has to be freely given, specific, informed and unambiguous, and it has to be recorded. A signature on a treatment form covering "photographs for clinical records" is not marketing consent, and no amount of internal assumption converts it into one.

Specific means specific. The agreement should name the clinic entity that will publish, describe the intended use — which channel, and for how long — and say plainly what the patient is entitled to do about it. It should be separable from the care agreement, so that declining is genuinely possible without any implication for treatment, and it should be capable of being withdrawn. Withdrawal has to be as straightforward as giving consent, which in practice means a named route to request removal, and a realistic account of what can and cannot be recalled once something has been shared or reposted.

Children need more care, not less. Parental or guardian consent handles one half; the child's own assent matters too, and a child who is old enough to object should not be overruled by a consent form. Photography of children for marketing also runs into the advertising rules on directing certain marketing at under-18s, which apply to the content itself and to where it is placed.

The same questions apply to staff and contractors. A team photograph is staff personal data, it needs a sensible basis of its own, and "we've always used that photo" is not one. Where a clinic uses paid models or stock imagery, the imagery must not be presented as a real patient's result — that is a separate advertising problem, and it is the sort of presentation the ASA has consistently treated as misleading. Where an agency is involved at all, it should be working from assets the clinic has consented to use, and it should hold a written processor contract covering what it does with them.

The CAP Code reaches a clinic's own organic social content. Its scope covers "advertisements and other marketing communications by or from companies... in other non-paid-for space online under their control, that are directly connected with the supply or transfer of goods, services...", and for content on social platforms the Code applies where, among other criteria, the marketer has a UK registered company address, a UK public authority or body imposes CAP Code compliance as a licensing condition, the content appears on a .uk domain, or the marketing is paid for and targets people in the UK. Since the scope explicitly excludes editorial content, this is about a clinic's promotional posts rather than a news article the clinic had no part in.

The testimonial rules are concrete and worth knowing by number. Rule 3.47 requires documentary evidence that a testimonial or endorsement is genuine and contact details for the person who gave it. Rule 3.48 requires that a testimonial relates to the advertised product. Rule 3.49 requires that factual claims appearing in a testimonial do not mislead. Rule 3.50 requires permission before featuring it. Rules 3.44 to 3.46 extend the same logic to reviews: no fake consumer reviews, incentivised reviews must be made clear, and reviews must not be published in a way that misleads — which includes the common practice of only showing the positive ones. Any objective claim in the content still has to be substantiated under rule 3.7, and a testimonial does not provide that substantiation.

Health claims sit on top of all of that. Section 12 of the Code covers medicines, medical devices, health-related products, treatments, and beauty products. Rule 12.1 requires objective claims to be backed by evidence; rules 12.14.1 to 12.14.4 prohibit, among other things, using improper or misleading images of changes in the body and presenting a detailed case history that might prompt erroneous self-diagnosis. Rule 12.12 is unambiguous: prescription-only medicines or prescription-only medical treatments may not be advertised to the public. Rule 12.25 restricts cosmetic-intervention advertising from being directed at under-18s through the choice of media or context.

A clarifying phrase — results vary, individual outcomes differ — does not rescue a misleading claim. It does not substantiate the claim, and it does not make a specific outcome typical. What actually reduces the exposure is narrower: publish testimonials you can prove are real and permitted, keep them tied to the service being advertised, avoid holding them out as evidence of what a treatment does generally, and keep any clinical statement inside what a clinician has approved and what the evidence supports.

The comment box creates a specific hazard: a patient describes symptoms in public, and a reply would be advice. CAP Code rule 12.2 prohibits offering specific advice on, diagnosis of, or treatment for conditions requiring medical supervision outside the supervision of a suitably qualified health professional, and rule 12.2.1 prohibits offering diagnosis or suggesting treatment by correspondence through electronic communications. A public reply that answers "does this sound like...?" with anything resembling a clinical view sits squarely against both.

The operating rule that keeps a clinic out of that territory is a single split: we answer non-clinical questions — opening hours, location, services offered, how to book, where to park — and everything else is routed, unanswered, to a named person at the clinic. The routing needs a name, not a queue. "Escalated to the clinical team" is not a route; "routed to the duty clinician via the clinic's own secure channel" is. And the reply that moves the conversation should be short and free of clinical content: it acknowledges the message, states that clinical questions cannot be answered in public, and points to the clinic's own booking or contact route.

Two other cases need a rule before they arise. When a comment contains a complaint, it should go to the clinic's complaints process immediately rather than being managed as community management — a public thread is the wrong venue and the tone of a marketing reply is the wrong tone. When a comment suggests a person may be at risk — self-harm, crisis, safeguarding concerns — the response should not be a marketing response at all: no clinical judgement, no advice, nothing that implies the clinic is monitoring. The established signposts are the right move: emergency services for immediate danger, NHS 111 for urgent medical help, and Samaritans on 116 123 for anyone in distress, at any hour.

Where an agency or a non-clinician runs the inbox, this is the part of the service that most needs writing down: what may be answered, what must never be answered, who receives what, how quickly, and what gets logged. The log matters, because it is the only way a clinic can see what patients are actually asking, and because it is the evidence of how a regulated conversation was handled.

The most useful thing a clinic marketing report can do is resist the temptation to present a guess as a measurement. A patient who saw three posts, mentioned a friend's recommendation to the receptionist, and booked by phone was not a social media conversion — unless the clinic has the tracking to show it, which it usually cannot. Reporting that honestly is not a weakness in the report; it is the thing that makes the rest of the report believable.

Split the numbers into three tiers. Measured: what arrives with a record attached — a link click on a tagged link, a form submission that carries a campaign parameter, a call on a tracked number, a booking record with a source field. Inferred: patterns that line up in time but cannot be proven — an increase in enquiries about a specific service in the same month as a specific campaign, or a shift in how patients say they heard about the clinic. Unknown: word of mouth, GP and consultant referrals, local signage, and anyone who saw the content and then arrived by searching for the clinic's name. Name the unknowns explicitly rather than letting silence imply they do not exist.

What gets measured depends on what the clinic already has in place, and privacy rules constrain some of it. Analytics cookies and similar storage generally require consent under the PECR unless they are strictly necessary for the service the user requested, and advertising platforms expect a consent signal to be passed through — which means the data is only as complete as the consent it was collected under. That is a reason to favour sources that do not depend on cookies: enquiries that arrive with a stated source, booking records the clinic already keeps, call tracking where it exists, and profile-level insights from the clinic's own listings.

Choose a small number of numbers and keep them stable. At the enquiry stage, that usually means how many enquiries arrived and through which routes the clinic can identify. At the booking stage, how many of those enquiries became consultations, and what the clinic knows about the rest. Everything else — reach, saves, follower movement — is a diagnostic for the content, not evidence of the business outcome, and should be labelled that way so nobody confuses activity with effect.

Doing it in-house keeps knowledge, clinical context, and judgement close to the practice. Someone at the clinic knows what is changing in the service lines, and there is no lag between a decision and its consequences being visible. The limits are equally clear: the person doing it is usually doing something else as well, approvals still need clinical time, and the work stops when they are on leave or when the clinic is at its busiest — which are exactly the weeks when a clinic most needs its channels current.

Outsourcing buys continuity and production capacity, at the cost of context. The clinic stops being the bottleneck for production and becomes the bottleneck for approval, which is why the approval design in section 04 largely determines whether an outsourced arrangement works. An outside team also cannot judge clinical content, so the sign-off stays with the clinic regardless of who produces the work. Anyone promising otherwise is describing a compliance risk they will not be carrying.

The hybrid model usually fits an independent clinic best: the clinic owns the strategy, the clinical substance, and every approval; the outside partner owns production, scheduling, publishing, community triage, and reporting. That split keeps the regulated decisions where the accountability is and moves the repeatable work where the capacity is.

Whichever way you go, the deciding factors are unglamorous. Does a named person own the channel? Is there a written workflow with lead times? Does the model survive a leave period? Can it be handed over? Is the account ownership unambiguous? A clinic with a mediocre-but-owned in-house process will usually outperform a clinic with a sophisticated outsourced process nobody at the clinic is accountable for.

Generalist marketing agencies are not bad at marketing; they are simply being asked to operate inside constraints they have not worked in. A studio that has never handled a clinical claim will treat approval as a formality, will happily suggest a patient photograph it cannot consent, and will measure the work in engagement because it has nothing else to measure. The interview is where that shows up, and it is easier to see when the questions are about process rather than portfolio.

The first cluster of questions is about approval. Who writes the clinical claims, who signs them off, and how is that recorded? What happens when a clinician rejects a draft at the final stage — is that a broken process or a normal event? How do you handle a correction after publication? An agency that answers these in specifics is describing a workflow it runs; one that answers with enthusiasm is describing a workflow it intends to improvise.

The second cluster is about data. How does patient material move between the clinic and the agency, and does the agency hold a written processing contract for it? Who holds the account credentials and the analytics, and what happens to them at the end of the engagement? What is the agency's own position on patient imagery — will it ever source it, and on what terms? These questions also establish who the controller is, which matters more than any clause about confidentiality.

The third cluster is about honesty under pressure. Ask how the agency reports attribution, and listen for whether it names what it cannot prove. Ask what it does not do — the clinics it turns down, the claims it refuses to make, the platforms it will not run for a regulated service. Ask for two clinic references and ask those clinics what the agency said no to. An agency with no limits is not compliant; it simply has not been tested yet.

This guide is written from an England-first operational standpoint, because that is where the care-regulation context sits for the audience it addresses. The Care Quality Commission registers providers of regulated activities in England and assesses them against the fundamental standards; it does not approve, review, or police marketing copy, and it does not sign off claims. A clinic's registration status is a fact about the clinic that marketing may state accurately, and it is not a marketing credential. Ratings are published, and where a clinic quotes one it should be quoted as published, in context, without implying an endorsement that does not exist.

Outside England the care regulator changes, and the marketing work does not. Scotland: the Care Inspectorate, with Healthcare Improvement Scotland for healthcare services. Wales: Care Inspectorate Wales, with Health Inspectorate Wales. Northern Ireland: the Regulation and Quality Improvement Authority. What does not change is the advertising framework, which applies across the UK, or the data-protection framework, which is UK-wide — so a Scottish or Welsh clinic reading this guide can use the governance, consent, and claims sections unchanged, and should substitute its own care regulator for the references to the CQC.

Professional regulation is a separate layer again, and it follows the practitioner rather than the premises: the GMC for doctors, the NMC for nurses, midwives and nursing associates, the HCPC for allied health professionals including physiotherapists, and the GDC for dental professionals. Professional codes contain their own communication and honesty duties, and where they are stricter than the advertising rules, the stricter standard governs. The practical consequence for clinics is that a claim can be acceptable advertising and still be unacceptable to a practitioner's regulator, which is why clinical sign-off in section 04 sits with the clinician rather than with the marketing process.

What none of this provides is a compliance guarantee, and the guide does not offer one. Nothing here verifies that any particular post, consent form, or workflow is compliant, and no framework described here appoints GlyphicX to police the clinic's marketing. Those decisions — what gets published, what a patient is asked to consent to, what claim is substantiated — remain with the clinic and its clinical and legal governance. Reading a guide is a starting point for asking better questions of the people who do carry that accountability, not a substitute for them.